MRNA
NASDAQ · Biotechnology
Moderna Inc
$59.35
-4.62 (-7.22%)
Earnings History
| Date | Quarter | EPS Est | EPS Actual | Surprise | Surprise % | Result |
|---|---|---|---|---|---|---|
| May 1, 2026 | Q2 FY2026 | $-2.61 | — | — | — | — |
| Feb 13, 2026 | Q1 FY2026 | $-2.70 | — | — | — | — |
Related Earnings News
AbbVie Nears $10.9B Apogee Takeover, Healthcare Stocks in Focus
Moderna Shares Surge on Positive FDA Staff Review for mRNA Flu Vaccine
Moderna Stock Surges 8% Amid Nasdaq Rally, Cancer Vaccine Progress in Focus
Moderna Shares Surge on Hantavirus Vaccine Interest After Andes Virus Outbreak on Cruise Ship